established in 2006. We are a listed company on main board of Hong Kong Exchange with KDL Medical as stock name and HK1501 as stock code.
We take up a leading position in the market of cardiovascular interventional device. We are one of the minority medical device manufacturers in China with the complete industrial chain which consists of several competence including independent mold tooling, product R&D, equipment developing and sterilization. We have obtained ISO13485, CE and FDA certification. Our products are exported to the United States, Europe and more than 50 other countries and regions.
Currently we have 12 subsidiaries, each one focuses on different types of interventional or implanted therapies. The spirit of our enterprise,"Team is the cornerstone of enterprise; Innovation is the engine of development; Execution is key to success." continuously enhances the ability of independent innovation and develops independent intellectual property products.
As at June 30,2021, we have an aggregate of 23 National Medical Products Administration of China registration certificates for Class III, 18 Shanghai Medical Products Administration registration certificates for Class II medical devices, 40 European CE certificates and 13 United States FDA approvals